Gracell Biotechnologies
Stock Forecast, Prediction & Price Target
Gracell Biotechnologies Financial Estimates
Gracell Biotechnologies Revenue Estimates
Gracell Biotechnologies EBITDA Estimates
Gracell Biotechnologies Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $366K 0% | $0 -100% | Avg: $920K Low: $1.03M High: $739.75K avg. 0% | |||
Net Income
% change YoY
| $-197.16M N/A | $-465.88M -136.29% | $-607.50M -30.40% | Avg: $-57.23M Low: $-66.19M High: $-43.21M avg. 90.57% | |||
EBITDA
% change YoY
| $-206.83M N/A | $-385.12M -86.20% | $-592.58M -53.86% | Avg: $552K Low: $621.09K High: $443.85K avg. 100.09% | |||
EPS
% change YoY
| -$3.01 N/A | -$7.08 -135.21% | -$5.65 20.19% | Avg: -$0.53 Low: -$0.62 High: -$0.4 avg. 90.57% | |||
Operating Expenses
% change YoY
| $214.39M N/A | $463.93M 116.39% | $624.65M 34.64% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Gracell Biotechnologies stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 90.57% in 2025-2025.
We have gathered data from 3 analysts. Their low estimate is -66.19M, average is -57.23M and high is -43.21M.
What is Gracell Biotechnologies stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is $1.03M, average is $920K and high is $739.75K.
What is Gracell Biotechnologies stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 90.57% in 2025-2025.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.62, average is -$0.53 and high is $-0.40.
What is the best performing analyst?
In the last twelve months analysts have been covering Gracell Biotechnologies stock. The most successful analyst is Louise Chen.